Stefan Yee

chairman and non – executive director

Mr. Stefan Yee has more than 30 years of experience in audit, corporate law, mergers and acquisitions, corporate finance.

Mr. Stefan Yee has more than 30 years of experience in audit, corporate law, mergers and acquisitions, corporate finance, investment banking and private equity with companies as KPMG, Linklaters, the Flemish investment bank Lessius, the Belgian Corporation for International Investment (SBI/BMI), Beluga (Euronext Brussels) and as the founder and CEO of the PE Group, a Belgian privately held private equity firm. Stefan is, and has been an investor and/or board member of several listed and private companies such as, amongst others, Beluga, Encare group (Mensura), AXI, The Reference, Alro Holdings, Loomans Group, United Brands, Capco, Faseas International (Spacewell), HD Partners (Dekabo group), AED Rent, UnifiedPost Group, NRG New Generation, Axiles Bionics, including several healthcare companies (Docpharma (formerly Euronext Brussels), Uteron Pharma and Imcyse). Stefan holds Masters degrees in Law and Business Management from the Universities of Brussels (VUB and ULB Solvay Business School) and the University of Chicago (as a BAEF Fellow).

Leon Van Rompay

non – executive director

Leon Van Rompay has more than 40 years’ experience in the pharmaceutical market. During his professional career he served in.

Leon Van Rompay has more than 40 years’ experience in the pharmaceutical market. During his professional career he served in several positions including country & area manager (covering major territories) and board member of the Zambon Group. He was founder and CEO of Docpharma, a Belgian based generics company that was listed on Euronext and served on different boards including Ecodis and Uteron Pharmaceuticals. He was a founding member of BIGE/IBES (Belgian Institute for Health and Economics), the B.G.A. (Belgian Generic Association), BAPIE (Belgian Association of Parallel Import and Export) and was an executive committee member and board member of the Belgian Pharmaceutical Industry Association. He also was a member of the pharmaceutical deontological commission and responsible for this commission in the industry association executive committee.

Marc Foidart

independent director

Marc Foidart obtained a Master in Business Engineering from the University of Liège (1998). He is co-founder of EKLO ASBL.

Marc Foidart obtained a Master in Business Engineering from the University of Liège (1998). He is co-founder of EKLO ASBL, Member of the Executive Committee of Noshaq SA in charge of the Life Sciences sector, CEO of B2H SA, the public company superseding the Liege life sciences ecosystem, and Investment Manager of Epimede SA, a EUR 50 million Belgian based private high-tech growth fund. He has more than 15 years of experience in strategic consulting and investment at all stages of development of small and medium high tech- high growth life sciences enterprises. He played a key role in several financing rounds at critical development stages of various Belgian young biotech companies among which: Mithra Pharmaceuticals SA, Imcyse SA, Uteron Pharma SA, PDC Line Pharma SA, Diagenode SA. As an entrepreneur, Marc Foidart is Co-Founder and past CEO of Arlenda SA, a spin-off company of the University of Liège providing expert statistical solutions to the pharmaceutical, chemical and environment industries. He is also Co-Founder and Executive Chairman of Eyed Pharma SA, a start-up company developing innovative controlled release microimplants in ophthalmology. Marc Foidart has been associate professor at the University of Liege since 2011.

Carolyn Myers

independent director

Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading health care.

Dr. Carolyn Myers is an accomplished senior executive with extensive experience creating, growing, and leading health care businesses. She is currently Principal of Bioensemble Ltd, a business strategy consulting firm that advises C-suite executives of small and medium size companies on a comprehensive range of drug development, commercial and business development services. Carolyn’s experience comes from having led many businesses in their growth strategies. At Allergan (formerly Actavis), she was the Vice President of Global Business Development and Alliance Management with a focus on expanding product portfolios. At Forest Laboratories (acquired by Actavis), Carolyn was the Vice President of the CNS marketing group responsible for marketing and sales of established and new products. At Mylan she held two different leadership positions including

President of Mylan Technologies, a division focused on developing generic transdermal systems and President of Dey Laboratories having full P&L responsibility to develop, manufacture and sell innovative respiratory products. Carolyn is also an advisor to several start-up organizations and capital investors.

Carolyn earned a PhD in Genetics from the University of British Columbia and an MBA from Rutgers University.

James Gale

independent director

James (Jim) Gale is the founding partner of Signet Healthcare Partners. Jim has over 30 years of healthcare investing and finance experience.

Jim is a Managing Director in Signet Fund IV and is currently the Chairman of the Board of Alpex Pharma S.A., Knight Therapeutics Inc. (TSX: GUD), Teligent (NSDQ: TLGT, formerly IGI Laboratories), and also serves on the Board of Directors of Bionpharma, Chr. Olesen Synthesis A/S, CoreRx, LeonNanodrugs GmbH, Pharmaceutics International (Pii), Advantice Health, and RK Pharma. Prior portfolio company boards include Arbor Pharmaceuticals, Amarin Corporation, eResearch Technologies Inc., and Valera Pharmaceuticals.

Prior to founding Signet, Jim was head of principal investment activities and head of investment banking for Gruntal & Co., LLC. While at Gruntal, he made a number of investments including Andrx Corporation, Royce Laboratories (merged with Watson Pharmaceuticals), Lifecell Corporation, Neurocrine Biosciences, and BML Pharmaceuticals (acquired by Endo Pharmaceuticals).

Chris Buyse

Independent Director

Chris Buyse has more than 30 years of international expertise across the healthcare sector.

Chris is currently Managing Director of Fund+, the largest Belgian life sciences-dedicated venture capital fund and serves as member of the board of directors of several European companies listed on Nasdaq and Euronext, including iTeos Therapeutics, Celyad and Inventiva Pharma. Chris is also a Director of the Francqui Foundation, among other private mandates. Chris holds a Master’s Degree in applied economic sciences from the University of Antwerp, and an MBA from the Vlerick School of Management in Ghent.

Stijn Van Rompay

chief executive officer, co-founder and acting chief financial officer

Mr. Stijn Van Rompay has over 20 years of experience in leadership positions at various pharmaceutical companies.

Stijn co-founded and was the CEO of Alter Pharma, a high-growth pharmaceutical company focused on the development of complex generics and pharmacy-related product sales. He was also co-CEO of Uteron Pharma, a company focused on innovative female healthcare products.

Prior to these positions, Stijn was CFO and later, CEO of Docpharma (formerly quoted on Euronext Brussels) a generics and medical-device company. Under his leadership, the companies recorded strong growth and value creation. He also holds several non-executive director positions in the biotech sector, and acts as an advisor to venture capital investors. Stijn holds a Master’s degree in Applied Economics from the University of Antwerp.

Thomas Jacobsen

chief business development officer & co-founder

Mr. Thomas Jacobsen has over 20 years of experience in the pharmaceutical industry, with expertise in operational management, business development, licensing, and research and development.

He co-founded Alter Pharma, a pharmaceutical company focused on the development of complex generics and pharmacy-related product distribution. Prior to this, he worked with Docpharma, a generics and medical-device company that was acquired by Matrix Laboratories/Mylan Laboratories, where he worked on out-licensing of Docpharma’s products. Thomas started his career in the Scandinavian-based generics company Alternova, where he was responsible for licensing, product registration and launches. Thomas holds a Master’s Degree in Pharmacy from the University of Copenhagen and a Business Degree from Copenhagen Business School.

Dietmar Aichhorn

chief operating officer

Dr. Dietmar Aichhorn, PhD, has over 20 years of experience in various scientific roles within the pharmaceutical industry.

Over the course of his career at Sandoz, Mylan, Innovacell, ViraTherapeutics and Polpharma Biologics, Dietmar has held several senior management positions of increasing responsibilities including Head Clinical Development and Head Development. Dr. Dietmar Aichhorn is an expert in the fields of technical development, clinical development and regulatory affairs in the US, EU and other key geographies. Most recently, Dietmar had an assignment at Polpharma Biologics, where he was responsible for the clinical development of monoclonal antibodies, as well as overseeing all scientific affairs. Dietmar graduated as chemical engineer in Linz but has perfected his project management skills at the university of Vienna.

Koenraad Van der Elst

chief legal officer

Mr. Koenraad Van der Elst has more than 30 years of experience as an in-house and external legal and general counsellor for various listed companies.

Koenraad served as General Counsel at Metris (currently Nikon Metrology), and acted as Secretary General & General Counsel of PUNCH INTERNATIONAL, a Belgian company listed on Euronext Brussels. He was also General Counsel & Secretary to the Board of PUNCH GRAPHIX plc, a company listed on the London Stock Exchange (AIM), and President of the Supervisory Board of PUNCH TECHNIX, a company listed on Euronext Amsterdam. Between 1995 and 2002, Koenraad was the Director of Legal Documentation at the Investment Banking Department (corporate finance & capital markets) of Generale Bank/Fortis Bank and was involved in most capital market transactions in Belgium (take-over bids, exchange offers, initial public offerings, etc.), as well as in a large number of corporate finance deals (M&A, advisory, fairness opinions, mergers, restructurings, etc.), at local, cross-border and international levels.

In addition, Koenraad was an assistant Professor at the University of Brussels (VUB) in Financial Law. He holds a law degree from the University of Brussels (VUB) and an MBA from EHSAL Brussels.

Grow with us

We are driven to continuously innovate existing medications and offer meaningful benefits to patients, physicians and payors.

Why join us

The key to success is an exceptional work force. Great people generate great results. As a young, entrepreneurial company, Hyloris fosters creativity, courage, and professionalism.
At Hyloris you will be part of multicultural and multidisciplinary team who will support you to further develop and grow your personal skills.

We strive to create an exciting and dynamic working environment in which you will be challenged to take initiative, contributing to the success of the company.

Interested in joining our mission to address important healthcare needs and deliver relevant improvements for patients, healthcare professionals and payors? Check out our vacancies below.

We look forward to hearing from you.

Latest vacancies

Business Analyst

Location: Liège Belgium

view vacancy

We are currently looking for a talented Business Analyst. The successful candidate must either have proven experience in data analysis and a background in the pharmaceutical industry or a healthcare degree, with strong analytical skills.

The job description

As Business Analyst, you will:

  • Provide our Business Development department with market analysis data and assist in the preparation of business cases and related tasks:
    • Perform market analysis for selected products using data as well as scientific literature to identify or evaluate new opportunities.
    • Perform analysis of prices, reimbursement, and market access in general.
    • Prepare business cases for new and existing products and maintain an updated overview of the available business cases.
    • Assist in monitoring and tracking of competitors and products (approvals, patent listings, market dynamics, etc.).
    • Assist in the preparation of commercial product presentations.
  • Identify new opportunities directly or through contact to universities, hospitals, and other partners.

Your professional profile

  • Strong educational background (Degree in Life Sciences or Business).
  • Entry level experience in the pharmaceutical industry. Previous experience with market and competition analysis is an asset.
  • Languages: English. French or Dutch is an asset.

Your abilities

  • Strong analytical skills.
  • Detail-oriented with the ability to work with big amount of data.
  • Excellent IT skills especially with Excel and Power Point, good understanding of analysis tools (pivot tables, charts etc).
  • Understanding the scientific principles.
  • Demonstrated ability to work in multidisciplinary teams.
  • Good self-starter, with ability to work independently.
  • Strong communication skills both oral and written.
  • Very good English skills (written and oral), French and/or other languages are an asset.
  • Capacity to react in unexpected situations and changing priorities.
  • Good understanding of and respect for cultural differences and the capacity to work effectively in a multicultural environment.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply
Senior Scientist Analytical Chemistry

Location: Liège Belgium

view vacancy

We are currently looking for a Senior Scientist Analytical Chemistry. The successful candidate will perform pharmaceutical laboratory operations in a start-up environment.

The job description

As Senior Scientist Analytical Chemistry you will:

  • Set-up new laboratory operations and implement systems and process to ensure compliance & data integrity.
  • Perform the laboratory activities for analytical development.
  • Perform and optimise current ongoing & new projects in parenteral and liquid oral dosage forms such as solution, suspension, and solid dosage forms such as oral tablets, capsules dosage form etc.
  • Be responsible for the full effective utilisation of instruments, their qualification, maintenance, and planning of the work to ensure timely delivery of tasks assigned.
  • Participate in technical discussion, present, compile and report relevant testing results, make conclusions.
  • Develop and validate analytical methods using chromatographic (HPLC, GC) and spectroscopic techniques (UV) per ICH, USP, US FDA, EMA requirements. Prior experience with mass spectrometry (MS) techniques and interpretation of respective spectra preferable.
  • Collaborate with Hyloris’ team of globally experienced scientists.
  • Support the formulation R&D team by testing API & finished product as per requirement of the experiment.
  • Execute laboratory operations, plan, schedule and implement experimental designs for analytical projects.
  • Develop and validate analytical methods as per regulatory standards for all products in the pharmaceutical development pipeline based on requirement.
  • Collaborate on pharmaceutical development plans with third party CRO/CDMO. Co-ordinate all third-party analytical testing work such as E&L, Elemental impurities, Residual solvents, Particle Size Distribution testing and validation, BET, Microbiology, Packaging Material evaluation etc.
  • Execute analytical development lab studies, technology transfers, method transfers, method verifications and method validation work in compliance with GMP/ICH/USFDA guidelines.
  • Participate in review of Submission Documents for Pre-IND, IND, NDA, as well as Quality GMP documents such as SOP’s, OOS investigations, CAPA, etc.

Your professional profile

  • Minimum Qualification: (Professional) Bachelor in Sciences (Chemistry, Pharmaceutical or allied / equivalent).
  • Minimum Experience: +7 years industrial experience in pharmaceutical R&D.
  • Languages: English [written and verbal] – French is an asset.
  • Computer literate: MS office suite, Empower software (or equivalent), Basic statistical calculations.

Your abilities

  • Demonstrates strong work ethics, and effective written and verbal communication skills.
  • Strong analytical/formulation skills, good negotiator/diplomat, enabler.
  • Strong interpersonal skills, a collaborative and trust enabling working style, building partnerships among key stakeholders.
  • Organizational aptitude to be part of an outstanding team.
  • Adaptability, flexibility, independence, and resourcefulness to both lead a big vision strategy while also willing to roll-up-sleeves and multi-task to thrive in a growing environment.
  • To have essential professional attributes include a detailed-oriented analytical thinking, a team-player attitude, respect and understanding for cultural differences in different countries, and efficient utilization of time and resources.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply
Scientist Formulation Design

Location: Liège Belgium

view vacancy

We are currently looking for a Scientist Formulation Design. The successful candidate will perform pharmaceutical laboratory operations in a start-up environment.

Job description

As a Scientist Formulation Design you will:

  • Execute pharmaceutical formulation development activities in liquid, injectable, solid oral dosage forms, review & compile R&D data.
  • Support new laboratory operations and implement systems and process to ensure compliance & data integrity.
  • Collaborate with Hyloris’ team of globally experienced team members in formulation and analytical.
  • Execute, document all the formulation experiments, manage stability samples and participate in technical discussion on product development.
  • Execute all formulation experiments as per study design, protocol and collaborate with analytical scientist to achieve timely results.
  • Execute development and scaling-up activities of pharmaceutical dosage forms
  • Prepare, compile, review pharmaceutical development documents such as QBD development report, protocols, study designs, stability reports etc.
  • Participate in submission batch manufacturing, technology transfers, scale up, GMP batch manufacturing for products under development.
  • Participate in review of submission documents for Pre-IND, IND, NDA, as well as quality GMP documents such as, SOP’s, OOS investigations, CAPA etc.

Your professional profile

  • Minimum Qualification: (Professional) Bachelor in Sciences (Chemistry, Pharmaceutical or allied / equivalent).
  • Minimum Experience: +3 years industrial experience in pharmaceutical R&D.
  • Languages: English [written and verbal] – French is an asset.
  • Computer literate: MS office suite, Design Expert software (or equivalent), Basic statistical calculations.

Your abilities

  • Demonstrates strong work ethics, and effective written and verbal communication skills.
  • Strong analytical/formulation skills, good negotiator/diplomat, enabler.
  • Strong interpersonal skills, a collaborative and trust enabling working style, building partnerships among key stakeholders.
  • Organizational aptitude to be part of an outstanding team.
  • Adaptability, flexibility, independence, and resourcefulness to both lead a big vision strategy while also willing to roll-up-sleeves and multi-task to thrive in a growing environment.
  • To have essential professional attributes include a detailed-oriented analytical thinking, a team-player attitude, respect and understanding for cultural differences in different countries, and efficient utilization of time and resources.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply
Business Development Coordinator

Location: Liège Belgium

view vacancy

We are currently looking for a Business Development Coordinator. The successful candidate will be responsible for the coordination of activities that could potentially lead to the expansion of the company’s product portfolio. He/she will report into the Chief Business Development Officer.

Job description

As Business Development Coordinator, you will:

  • Build and maintain business cases, together with business analysts and our market access team.
  • Coordinate due diligence activities, with the support of R&D, regulatory, clinical, quality and finance departments.
  • Assist in licensing and partnering activities.
  • Maintain the company’s various business development databases.
  • Identify new development or licensing opportunities and partners, together with our business analysts.
  • Prepare business cases with the support of R&D, regulatory and clinical departments.
  • Build and maintain a competitor overview and coordinate input with business analysts (approvals, clinical trials, patent listings, market dynamics, etc.).
  • Build connections with KOLs, local focus groups and healthcare professionals together with business analysts, evaluate and bring new ideas.
  • Help business analysts to manage market surveys and analysis.
  • Manage calls and status reports of projects under evaluation.

Your professional profile

  • Minimum Qualification: MSc or higher in a life science discipline.
  • Minimum Experience: 5 years of experience in the pharmaceutical industry.
  • Languages: English (written and oral).

Your abilities

  • Communication and motivational skills.
  • Strong interpersonal skills with the ability to influence others in a positive and effective manner.
  • Demonstrated ability to contribute to a continuous learning and process improvement environment.
  • Strong commercial skills and abilities in negotiations.
  • Ability to manage teams in person and remotely.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply
Head of R&D Lab

Location: Liège Belgium

view vacancy

We are currently looking for a Head of R&D Lab. The successful candidate will be responsible for building-up and managing the entire laboratory operations.

Job description

As our Head of R&D Lab, you will:

  • Lead and manage the entire laboratory operations in a start-up environment.
  • Build and lead a laboratory team including lab technicians, analytical & formulation scientists.
  • Establish new laboratory operations and implement systems and process to ensure compliance & data integrity.
  • Manage the entire laboratory operations, plan, schedule and implement experimental designs of both formulation and analytical activities.
  • Plan, perform and optimise projects in parenteral and liquid oral dosage forms (e.g. solution, suspension), and solid dosage forms (e.g. oral tablets, capsules dosage form) etc.
  • Develop, validate, and review all analytical methods as per regulatory standards for all products in the R&D pipeline.
  • Utilise all available resources effectively to support development of in-house or CRO/CMO based projects.
  • Review of development documents, protocols, and study designs, generated by third party CRO/CDMO.
  • Participate in scheduling / planning / executing formulation study designs as per project requirement.
  • Participate in development, technology transfer, method transfer, method verification, method validation in compliance with GMP guidelines.
  • Participate in review of Submission documents for Pre-IND, IND, NDA, as well as Quality GMP documents, for example: SOP’s, OOS investigations, CAPA etc.

Your professional profile

  • Minimum Qualification: MSc / PhD in analytical sciences / pharmaceutical sciences
  • Minimum Experience: 10 + years industrial experience in pharmaceutical R&D
  • Languages: English (written and verbal) – French is an asset

Your abilities

  • Demonstrates strong work ethics, and effective written and verbal communication skills.
  • Strong analytical/formulation skills, good negotiator/diplomat, enabler.
  • Strong interpersonal skills, a collaborative and trust enabling working style, building partnerships among key stakeholders.
  • Organizational aptitude to build, lead and develop an outstanding team.
  • Adaptability, flexibility, independence, and resourcefulness to both lead a big vision strategy while also willing to roll-up-sleeves and multi-task to thrive in a growing environment.
  • To have essential professional attributes include a detailed-oriented analytical thinking, a team-player attitude, respect and understanding for cultural differences in different countries, and efficient utilization of time and resources.

About our company

Hyloris is a specialty biopharma company identifying and unlocking hidden potential in existing medications for the benefit of patients and the healthcare system. Hyloris applies its knowhow and technological innovations to existing pharmaceuticals and has built a broad proprietary product pipeline that has the potential to offer significant advantages over currently available alternatives. Hyloris currently has two partnered, commercial-stage products: Sotalol IV for the treatment of atrial fibrillation, and Maxigesic® IV, a non-opioid analgesic for the treatment of pain. The Company’s development strategy primarily focuses on the FDA’s 505(b)2 regulatory pathway, which is specifically designed for pharmaceuticals for which safety and efficacy of the molecule have already been established. This pathway can reduce the clinical burden required to bring a product to market, and significantly shorten the development timelines and reduce costs and risks. Hyloris is based in Liège, Belgium. For more information, visit www.hyloris.com and follow-us on LinkedIn.

Our values

Our talented staff work in accordance with our company values:

  • We are proud of our entrepreneurial culture and foster open communication, mutual respect, professionalism and efficient decision-making and we believe that our multicultural organisation is one of our most important competitive advantages.
  • We believe that timely and well considered decisions as a response to emerging opportunities and ideas is the key to our success.
  • We believe that the success of the company lies in the competence, dedication, and motivation of each of our employees.
  • We believe that freedom returns flexibility and empowerment returns commitment.

Download a PDF version HERE

Apply